ARC-520 Phase 1 - the reply I got from Arrowhead... | ARWR Message Board Posts

Arrowhead Pharmaceuticals, Inc.

  ARWR website

ARWR   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1690 of 8145  at  3/20/2014 2:43:31 PM  by

latebloomer


 In response to msg 1688 by  Steve_382
view thread

Re: ARC-520 Phase 1 - the reply I got from Arrowhead...

Here's the reply I got from Arrowhead today:

Hi Linda,
Thanks for your interest. There has been some speculation about the Phase 1 trial based on an update that was made in February to the clinical trials.gov entry for ARC-520 that changed estimated enrollment to 48. This does not reflect any change to previous guidance we have given about retaining the right and flexibility to add additional cohorts to the Phase 1 if we think it will be helpful for the program. It is still an open study, so I can’t comment specifically about any actions or plans beyond the guidance we have given.

My best,

Vincent Anzalone, CFA


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 8     Views: 371
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1703 Re: ARC-520 Phase 1 - the reply I got from Arrowhead... Sir_Holler 0 3/21/2014 10:26:26 AM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2016 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.

Loading...